Sandimmune and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Sandimmune (cyclosporine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Cellulitis when taking Sandimmune. It is created by eHealthMe based on reports of 6,679 people who have side effects when taking Sandimmune from the FDA, and is updated regularly.

What is Sandimmune?

Sandimmune has active ingredients of cyclosporine. eHealthMe is studying from 6,694 Sandimmune users. Check the latest studies of Sandimmune.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,081 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 22, 2026

6,679 people reported to have side effects when taking Sandimmune.
Among them, 30 people (0.45%) have Cellulitis.

Among these 30 people:

How long have people been on Sandimmune when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Sandimmune? *

female: 41.38 %
male: 58.62 %

What is the age of people who have Cellulitis when taking Sandimmune? *

What are other drugs people take besides Sandimmune? *

What are other side effects people have besides Cellulitis? *

Cytomegalovirus Infection: 7 people, 23.33%
Fever: 7 people, 23.33%
Blood Creatinine Increased: 6 people, 20.00%
Impaired Healing: 5 people, 16.67%
Joint Pain: 4 people, 13.33%
Rashes (redness): 4 people, 13.33%
Death: 4 people, 13.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 13.33%
Dehydration (dryness resulting from the removal of water): 3 people, 10.00%
Pneumonia: 3 people, 10.00%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 3 people, 10.00%
Aplastic Anemia: 2 people, 6.67%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 1 person, 3.33%
Polyomavirus-Associated Nephropathy (polyomavirus-associated kidney disease): 1 person, 3.33%
Pneumonia: 1 person, 3.33%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 3.33%
Osteoporosis (bones weak and more likely to break): 1 person, 3.33%
Metastases To Bone (cancer spreads to bone): 1 person, 3.33%
High Blood Pressure: 1 person, 3.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sandimmune and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sandimmune:

Sandimmune (6,694 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Sandimmune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,081 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Sandimmune) and Sandimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.